Patents by Inventor John Quillian Walker, II

John Quillian Walker, II has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220199257
    Abstract: A computer-implemented method, system, and apparatus for providing interactive and analytical components that provide a comprehensive and dynamic tool for therapies to prevent and cure dementia-related diseases. The invention includes one or more computers that receive and store personal information for people, including personal background information, pre-existing conditions, current medications, genomic data and diagnostic information. The computers also generate synergic data containing compounded probability data specifying an expected adjustment of individual biological mechanisms from particular combinations of therapies. For each person, the computers process personal information and identify a subset of biological mechanisms that are principally affected by dementia-related diseases or the substantial risk of dementia-related diseases.
    Type: Application
    Filed: February 21, 2022
    Publication date: June 23, 2022
    Inventor: John Quillian Walker, II
  • Patent number: 11257593
    Abstract: A computer-implemented method, system, and apparatus for providing interactive and analytical components that provide a comprehensive and dynamic tool for therapies to prevent and cure dementia-related diseases. The invention includes one or more computers that receive and store personal information for people, including personal background information, pre-existing conditions, current medications, genomic data and diagnostic information. The computers also generate synergic data containing compounded probability data specifying an expected adjustment of individual biological mechanisms from particular combinations of therapies. For each person, the computers process personal information and identify a subset of biological mechanisms that are principally affected by dementia-related diseases or the substantial risk of dementia-related diseases.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: February 22, 2022
    Assignee: UMETHOD HEALTH, INC.
    Inventor: John Quillian Walker, II
  • Publication number: 20210327588
    Abstract: Methods, systems, and devices for solving the problem of more efficiently and consistently determining immune system status are disclosed herein. In one embodiment, a method includes receiving previous medical data associated with the first person, receiving current medical data associated with the first person, and determining immune system status data associated with the immune system based at least partially on the previous medical data and the current medical data. The method also includes generating a report including the immune system status data and transmitting the report to a graphical user interface (GUI), a printer, a computer log, and/or the like. The immune system status data may also include an overall assessment factor of the immune system of the first person.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 21, 2021
    Inventors: John Quillian Walker, II, Mark Clarence Zelek
  • Publication number: 20200058402
    Abstract: A computer-implemented method, system, and apparatus for providing interactive and analytical components that provide a comprehensive and dynamic tool for therapies to prevent and cure dementia-related diseases. The invention includes one or more computers that receive and store personal information for people, including personal background information, pre-existing conditions, current medications, genomic data and diagnostic information. The computers also generate synergic data containing compounded probability data specifying an expected adjustment of individual biological mechanisms from particular combinations of therapies. For each person, the computers process personal information and identify a subset of biological mechanisms that are principally affected by dementia-related diseases or the substantial risk of dementia-related diseases.
    Type: Application
    Filed: October 28, 2019
    Publication date: February 20, 2020
    Inventor: John Quillian Walker, II
  • Patent number: 10460842
    Abstract: A computer-implemented method, system, and apparatus for providing interactive and analytical components that provide a comprehensive and dynamic tool for therapies to prevent and cure dementia-related diseases. The invention includes one or more computers that receive and store personal information for people, including personal background information, pre-existing conditions, current medications, genomic data and diagnostic information. The computers also generate synergic data containing compounded probability data specifying an expected adjustment of individual biological mechanisms from particular combinations of therapies. For each person, the computers process personal information and identify a subset of biological mechanisms that are principally affected by dementia-related diseases or the substantial risk of dementia-related diseases.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: October 29, 2019
    Assignee: UMETHOD HEALTH, INC.
    Inventor: John Quillian Walker, II
  • Publication number: 20150213232
    Abstract: A computer-implemented method, system, and apparatus for providing interactive and analytical components that provide a comprehensive and dynamic tool for therapies to prevent and cure dementia-related diseases. The invention includes one or more computers that receive and store personal information for people, including personal background information, pre-existing conditions, current medications, genomic data and diagnostic information. The computers also generate synergic data containing compounded probability data specifying an expected adjustment of individual biological mechanisms from particular combinations of therapies. For each person, the computers process personal information and identify a subset of biological mechanisms that are principally affected by dementia-related diseases or the substantial risk of dementia-related diseases.
    Type: Application
    Filed: January 29, 2014
    Publication date: July 30, 2015
    Applicant: Muses Labs, Inc.
    Inventor: John Quillian Walker, II
  • Patent number: 6408335
    Abstract: Communications network performance is tested utilizing a test scenario simulating actual communications traffic on the network to be tested. The test scenario includes an endpoint node specific test protocol between an endpoint node pair including a first and associated second endpoint node on the network to be tested. A partner endpoint node test protocol is determined from the endpoint node specific test protocol and communicated to from the first endpoint node to the associated second endpoint node of the endpoint node pair. A plurality of endpoint node pairs may executed different endpoint node specific test protocols under a test scenario. A console node is provided on the network for establishing the test scenario and assigning the test scenario to endpoint node pairs and initiating execution of the test scenario. Performance data may be monitored at one of the endpoint nodes of each endpoint node pair and reported to the console node either as it is generated or after completion of the test.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: June 18, 2002
    Assignee: NetIQ Corporation
    Inventors: Peter James Schwaller, John Quillian Walker, II, Steven Thomas Joyce, Timothy Scott Huntley
  • Patent number: 6061725
    Abstract: Communications network performance is tested utilizing a test scenario determined based on a type of applications traffic expected on the network to be tested. A console node is provided on the network for establishing the test scenario and assigning the test scenario to endpoint nodes on the network to be tested. Each endpoint node is assigned an endpoint node specific test protocol. Execution of the test protocols by the endpoint nodes is initiated by the console node. Performance data such as throughput, transaction rate and response time may be monitored at selected ones of the endpoint nodes and reported to the console node either as it is generated or after completion of the test. The test scenario may be terminated when all endpoint node specific test protocols have completed execution or when any one endpoint completes execution of its test protocol. Multiple network protocols may be utilized within a single test scenario.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: May 9, 2000
    Assignee: Ganymede Software Inc.
    Inventors: Peter James Schwaller, John Quillian Walker, II, Steven Thomas Joyce, Timothy Scott Huntley
  • Patent number: 5937165
    Abstract: Communications network performance is tested utilizing a test scenario determined based on a type of applications traffic expected on the network to be tested. A console node is provided on the network for establishing the test scenario and assigning the test scenario to endpoint nodes on the network to be tested. Each endpoint node is assigned an endpoint node specific test protocol. Execution of the test protocols by the endpoint nodes is initiated by the console node. Performance data such as throughput, transaction rate and response time may be monitored at selected ones of the endpoint nodes and reported to the console node either as it is generated or after completion of the test. The test scenario may be terminated when all endpoint node specific test protocols have completed execution or when any one endpoint completes execution of its test protocol. Multiple network protocols may be utilized within a single test scenario.
    Type: Grant
    Filed: September 10, 1996
    Date of Patent: August 10, 1999
    Assignee: Ganymede Software, Inc
    Inventors: Peter James Schwaller, John Quillian Walker, II, Steven Thomas Joyce, Timothy Scott Huntley
  • Patent number: 5881237
    Abstract: Communications network performance is tested utilizing a test scenario simulating actual communications traffic on the network to be tested. A console node is provided on the network for establishing the test scenario and assigning the test scenario to endpoint nodes on the network to be tested. Each endpoint node is assigned an endpoint node specific test protocol. Execution of the test protocols by the endpoint nodes is initiated by the console node. Performance data such as throughput, transaction rate and response time may be monitored at selected ones of the endpoint nodes and reported to the console node either as it is generated or after completion of the test. The test scenario may be terminated when all endpoint node specific test protocols have completed execution or when any one endpoint completes execution of its test protocol. Multiple network protocols may be utilized within a single test scenario.
    Type: Grant
    Filed: September 10, 1996
    Date of Patent: March 9, 1999
    Assignee: Ganymede Software, Inc.
    Inventors: Peter James Schwaller, John Quillian Walker, II, Steven Thomas Joyce, Timothy Scott Huntley
  • Patent number: 5838919
    Abstract: Communications network performance is tested utilizing a test scenario simulating actual communications traffic on the network to be tested. The test scenario includes an endpoint node specific test protocol between an endpoint node pair including a first and associated second endpoint node on the network to be tested. A partner endpoint node test protocol is determined from the endpoint node specific test protocol and communicated to from the first endpoint node to the associated second endpoint node of the endpoint node pair. A plurality of endpoint node pairs may executed different endpoint node specific test protocols under a test scenario. A console node is provided on the network for establishing the test scenario and assigning the test scenario to endpoint node pairs and initiating execution of the test scenario. Performance data may be monitored at one of the endpoint nodes of each endpoint node pair and reported to the console node either as it is generated or after completion of the test.
    Type: Grant
    Filed: September 10, 1996
    Date of Patent: November 17, 1998
    Assignee: Ganymede Software, Inc.
    Inventors: Peter James Schwaller, John Quillian Walker II, Steven Thomas Joyce, Timothy Scott Huntley